Caliber Imaging & Diagnostics, formerly Lucid, Inc, has appointed William F. O’Dell to its board of directors, increasing the size of the board to nine members as the company restructures its global sales and marketing program.
O’Dell previously served as executive vice president of sales and marketing at Dusa Pharmaceuticals, where he helped negotiate the company’s sale to Sun Pharma for $230 million. Prior to that, he held several positions at West Pharmaceutical Services, ending as vice president of marketing and strategic business development.
Caliber is the maker of the VivaScope, a noninvasive point-of-care imaging technology with applications for dermatology, surgery, and research.
“During my years in the healthcare industry, I have learned that introducing innovative and disruptive technologies to the marketplace has been the cornerstone to success. I am extremely
encouraged by Caliber ID’s success in developing the VivaScope system,” O’Dell said. “Although Caliber already has a stellar group of customers that spans leading clinical and medical centers, cosmetic companies and academia, I believe there is much more potential in the marketplace for the VivaScope system. I look forward to working with Caliber’s management team to increase awareness and sales of VivaScope in the global markets.”
For more information, visit Caliber Imaging & Diagnostics.
